Chemotherapy for Uterus Cancer
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer -
Pregnancy-Associated Breast Cancer
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
Adjuvant systemic therapy for HER2-positive breast cancer - UpToDate
Effect of Number of Treatment Cycles of Adjuvant Chemotherapy on Clinical Outcomes | Research To Practice
4102-Breast adjuvant/neoadjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense | eviQ
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
BC Cancer Protocol Summary for Neoadjuvant or Adjuvant Therapy for Early Breast Cancer Using DOXOrubicin and Cyclophosphamide fo
Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study - ScienceDirect
Clatterbridge Centre for Oncology Chemotherapy Protocols
For the Patient: AC
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
Chemotherapy regimens for breast cancer. | Download Table
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Chemotherapy protocol definition form | Download Scientific Diagram
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy | SpringerLink
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
NICE Guideline Template
